Clinical Trial Update: Natural Killer Index From Hematopoietic Stem Cell Graft [NA]

View source ↗

Summary

Clinical trial update on the natural killer index derived from hematopoietic stem cell graft. The study is listed as completed and includes acute lymphoblastic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia

Snippet

Sponsor: Nantes University Hospital | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia | NA | Status: COMPLETED